ECOPRINT

Pollution, involves pesticides, nanoplastic and metallic nanoparticles. This cocktail dramatically alters human health from cancer to cognitive alterations. It also favors “pre-diseases” states such as obesity, metabolic disturbances, and inflammation. The end-point urine or hair dosages are non-relevant of damaged tissues. No technology exists to monitor human body contamination and its impact.

The aim of EcoPrint is to develop an innovative technology to decipher environmental body contamination. It is based on a specific bio-affinity strategy, making possible highly sensitive detection of fat environmental body contamination and impact.

EcoPrint's sampling technology gives access to the monitoring of damages tissues. It can be performed at home and processed remotely. It is highly sensitive compatible with the low dose environmental cocktail scenario. Moreover, it is low-cost compatible with a large scale preventive approach.

Pre-industrial prototypes and proof of concept of this technology have been done focusing on pesticides and more specifically glyphosate . Two medical devices have been designed to explore the active and storage human body pollution. the pre-clinical phase began in 2023.

EcoPrint provides for the first environmental footprint of the human body to detect the impact of pollution. It makes possible an adequate prevention concerning professional exposure as well as every citizen also widely exposed. It will pave the way to a new personalized environmental medicine. Veterinary and food applications are also possible.